Average Co-Inventor Count = 2.52
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Reviva Pharmaceuticals, Inc. (27 from 27 patents)
2. Xenoport, Inc. (10 from 142 patents)
3. Xero Port, Inc. (1 from 1 patent)
4. Revivia Pharmaceuticals, Inc. (1 from 1 patent)
39 patents:
1. 12053477 - Methods for treating pulmonary fibrosis
2. 10441590 - Methods for treating pulmonary hypertension
3. 10035761 - Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
4. 9975862 - Arylpiperazine derivatives and methods of utilizing same
5. 9907803 - Methods for treating attention deficit hyperactivity disorder
6. 9695116 - Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
7. 9604944 - Arylpiperazine derivatives and methods of utilizing same
8. 9302981 - Synthesis, methods of using, and compositions of cycloalkylmethylamines
9. 9296681 - Cycloalkylmethylamines
10. 9255076 - Arylpiperazine derivatives and methods of utilizing same
11. 9238625 - Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
12. 9096515 - Methods of using cycloalkylmethylamine derivatives
13. 8980883 - Arylpiperazine derivatives and methods of utilizing same
14. 8859552 - Methods of utilizing arylpiperazine derivatives
15. 8669285 - Synthesis, methods of using, and compositions of cycloalkylmethylamines